tiprankstipranks
Advertisement
Advertisement
Rezolute price target raised to $6 from $5 at BTIG
PremiumThe FlyRezolute price target raised to $6 from $5 at BTIG
15d ago
Rezolute price target raised to $14 from $10 at Maxim
Premium
The Fly
Rezolute price target raised to $14 from $10 at Maxim
15d ago
Rezolute Reports Positive Phase 3 Data for Ersodetug
Premium
Company Announcements
Rezolute Reports Positive Phase 3 Data for Ersodetug
15d ago
Rezolute Shares Expanded Phase 3 sunRIZE Data With FDA
PremiumCompany AnnouncementsRezolute Shares Expanded Phase 3 sunRIZE Data With FDA
1M ago
Rezolute Buy Rating Reiterated as CGM Data Offset Phase 3 Miss; $5 Price Target Maintained
Premium
Ratings
Rezolute Buy Rating Reiterated as CGM Data Offset Phase 3 Miss; $5 Price Target Maintained
1M ago
Rezolute presents results from Phase 3 sunRIZE study of ersodetug at PES 2026
Premium
The Fly
Rezolute presents results from Phase 3 sunRIZE study of ersodetug at PES 2026
2M ago
Rezolute provides update on sunRIZE study following Type B meeting with FDA
PremiumThe FlyRezolute provides update on sunRIZE study following Type B meeting with FDA
3M ago
Rezolute management to meet with Maxim
Premium
The Fly
Rezolute management to meet with Maxim
4M ago
Rezolute: Positive Risk‑Reward Outlook Despite sunRIZE Miss, Backed by Encouraging Hyperinsulinism Data and Solid Cash Position
Premium
Ratings
Rezolute: Positive Risk‑Reward Outlook Despite sunRIZE Miss, Backed by Encouraging Hyperinsulinism Data and Solid Cash Position
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100